Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

Post time 2024-5-9 21:54:11

DOI:https://doi.org/10.1016/S1473-3099(23)00756-9

Title:
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trialAuthor: Achim J Kaasch

Journal: The Lancet

URL: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00756-9/abstract

Date: 17 Jan 2024

Post time 2024-5-9 21:54:12

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

Best Answer

Viewed forums

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial Copy